These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 6368054)

  • 21. The occurrence of macroscopical pituitary calcifications in prolactinomas.
    Rasmussen C; Larsson SG; Bergh T
    Neuroradiology; 1990; 31(6):507-11. PubMed ID: 2352634
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prolactin secretion and menstrual function after long-term bromocriptine treatment.
    Rasmussen C; Bergh T; Wide L
    Fertil Steril; 1987 Oct; 48(4):550-4. PubMed ID: 3653413
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical response to CB-154 and the pituitary response to thyrotropin-releasing hormone-gonadotropin-releasing hormone in patients with galactorrhea-amenorrhea.
    March CM; Kletzky OA; Davajan V
    Fertil Steril; 1977 May; 28(5):521-5. PubMed ID: 404198
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Restoration of the prolactin response to sulpiride by metergoline administration in hyperprolactinemic patients.
    Ferrari C; Travaglini P; Caldara R; Moriondo P; Mattei A; Crosignani PG; Faglia G
    Neuroendocrinology; 1979; 29(5):338-45. PubMed ID: 503288
    [No Abstract]   [Full Text] [Related]  

  • 25. Endocrinology of menstrual disorders.
    Jacobs HS
    Practitioner; 1982 Feb; 226(1364):213-9. PubMed ID: 6806796
    [No Abstract]   [Full Text] [Related]  

  • 26. Bromocriptine treatment of 42 hyperprolactinaemic women with secondary amenorrhoea.
    Bergh T; Nillius SJ; Wide L
    Acta Endocrinol (Copenh); 1978 Jul; 88(3):435-51. PubMed ID: 354299
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Diagnosis of hyperprolactinaemias: respective value of response to THR and to bromocriptine (author's transl)].
    Murie N; Rio M; Scarabin JM; Auvray E
    Nouv Presse Med; 1978 Jun; 7(23):2035-40. PubMed ID: 97629
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment of prolactinoma based on the results of transsphenoidal operations.
    Saitoh Y; Mori S; Arita N; Nagatani M; Hayakawa T; Koizumi K; Tanizawa O; Uozumi T; Mogami H
    Surg Neurol; 1986 Oct; 26(4):338-44. PubMed ID: 3750191
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical disorders in patients with hyperprolactinaemia. Experience with 59 patients.
    Grunstein H; Clifton-Bligh P; Colagiuri S; Rushworth R; Robertson S; Wilkinson M; Posen S
    Med J Aust; 1984 Jan; 140(2):64-9. PubMed ID: 6694581
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prolactin and thyrotropin responses to thyrotropin-releasing hormone in patients with secondary amenorrhea: the effect of bromocriptine.
    Hirvonen E; Ranta T; Seppäla M
    J Clin Endocrinol Metab; 1976 Jun; 42(6):1024-30. PubMed ID: 819453
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Review: human prolactin--recent advances in physiology and therapy.
    Healy DL; Burger HG
    Aust N Z J Obstet Gynaecol; 1977 May; 17(2):61-78. PubMed ID: 20073
    [No Abstract]   [Full Text] [Related]  

  • 32. [Bromocriptine treatment of hyperprolactinemia].
    Gauer J; Heberling HJ; Stubert B; Richardt W; Lohmann D
    Z Gesamte Inn Med; 1985 Jul; 40(13):393-6. PubMed ID: 4036221
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dopamine agonist- and antagonist-induced modulation of pituitary gonadotrophin releasing hormone receptors are independent of changes in serum prolactin.
    Clayton RN; Bailey LC
    J Endocrinol; 1984 Aug; 102(2):215-23. PubMed ID: 6086802
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pituitary function in prolactinoma. Effect of surgery and postoperative bromocriptine therapy.
    Pelkonen R; Grahne B; Hirvonen E; Karonen SL; Salmi J; Tikkanen M; Valtonen S
    Clin Endocrinol (Oxf); 1981 Apr; 14(4):335-48. PubMed ID: 7261416
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hyperprolactinemia in cases of infertility and amenorrhea.
    Furuhjelm M; Rydner T; Carlström K
    Acta Obstet Gynecol Scand; 1980; 59(2):137-41. PubMed ID: 6773290
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of bromocriptine-induced pregnancy on prolactin-secreting pituitary tumours.
    Bergh T; Nillius SJ; Larsson SG; Wide L
    Acta Endocrinol (Copenh); 1981 Nov; 98(3):333-8. PubMed ID: 7293665
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Therapeutic use of bromocriptine in women with amenorrhea-galactorrhea and suspected pituitary microadenoma.
    Jewelewicz R
    Adv Biochem Psychopharmacol; 1980; 23():209-15. PubMed ID: 7395612
    [No Abstract]   [Full Text] [Related]  

  • 38. [Primary hyperprolactinemic amenorrhea. Report of 4 patients].
    Rudolf K; Smid I; Kunkel S; Bazsa-Kassai Z
    Zentralbl Gynakol; 1985; 107(14):894-8. PubMed ID: 3929499
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prolactinomas in women: current therapies.
    Robinson AG; Nelson PB
    Ann Intern Med; 1983 Jul; 99(1):115-8. PubMed ID: 6344716
    [No Abstract]   [Full Text] [Related]  

  • 40. Bromocriptine treatment of hyperprolactinaemic hypogonadism.
    Thorner MO; Besser GM
    Acta Endocrinol Suppl (Copenh); 1978; 216():131-46. PubMed ID: 347858
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.